# Cardlytics, Inc.: filings

CDLX · Nasdaq · CIK 1666071 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cdlx.md) · [Financials](/companies/cdlx/financials.md) · [Filings](/companies/cdlx/filings.md) · [Insiders](/companies/cdlx/insiders.md)

## Reports and events: 158 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 632, 8-K 103, 144 72, 3 30, SC 13G/A 27, 10-Q 26, S-8 15, SC 13G 12, 4/A 11, 10-K 9, UPLOAD 9, DEF 14A 8, DEFA14A 8, CORRESP 7, DRS/A 6, DRSLTR 6, 424B5 5, ARS 4, EFFECT 4, SC 13D/A 4, 3/A 2, 8-K/A 2, CT ORDER 2, POS AM 2, S-3 2, S-3/A 2, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 10-K/A 1, 424B4 1, 8-A12B 1, CERT 1, D 1, DEFR14A 1, DRS 1, POSASR 1, PRE 14A 1, S-1 1, S-1/A 1, S-3ASR 1, SC 13D 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-11 | 13:01 ET | [8-K](/filings/0001628280-26-061459.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-26-061459 |
| 2026-08-05 | 20:09 ET | [10-Q](/filings/0001628280-26-053340.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053340 |
| 2026-08-05 | 20:02 ET | [8-K](/filings/0001628280-26-053285.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053285 |
| 2026-06-03 | 20:26 ET | [8-K](/filings/0001628280-26-040351.md) | 3.01 Delisting notice; 3.03 Change to security holders’ rights | 0001628280-26-040351 |
| 2026-05-20 | 20:04 ET | [8-K](/filings/0001628280-26-036875.md) | 5.07 Shareholder vote results | 0001628280-26-036875 |
| 2026-05-12 | 20:10 ET | [8-K](/filings/0001628280-26-034107.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-034107 |
| 2026-05-07 | 20:20 ET | [10-Q](/filings/0001628280-26-032158.md) | Quarterly report, period 2026-03-31 | 0001628280-26-032158 |
| 2026-05-07 | 20:03 ET | [8-K](/filings/0001628280-26-032076.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-032076 |
| 2026-04-09 | 20:05 ET | [DEF 14A](/filings/0001628280-26-024446.md) | Proxy statement, period 2026-04-09 | 0001628280-26-024446 |
| 2026-03-24 | 20:17 ET | [8-K](/filings/0001628280-26-020811.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001628280-26-020811 |
| 2026-03-04 | 21:27 ET | [10-K](/filings/0001666071-26-000010.md) | Annual report, period 2025-12-31 | 0001666071-26-000010 |
| 2026-03-04 | 21:05 ET | [8-K](/filings/0001666071-26-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001666071-26-000008 |
| 2026-01-26 | 13:00 ET | [8-K](/filings/0001666071-26-000003.md) | 1.01 Entry into a material agreement | 0001666071-26-000003 |
| 2025-12-18 | 13:00 ET | [8-K](/filings/0001666071-25-000171.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001666071-25-000171 |
| 2025-12-05 | 13:04 ET | [8-K](/filings/0001666071-25-000166.md) | 5.02 Departure or appointment of officers or directors | 0001666071-25-000166 |
| 2025-11-05 | 21:19 ET | [10-Q](/filings/0001666071-25-000159.md) | Quarterly report, period 2025-09-30 | 0001666071-25-000159 |
| 2025-11-05 | 21:07 ET | [8-K](/filings/0001666071-25-000156.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001666071-25-000156 |
| 2025-10-02 | 11:58 ET | [8-K](/filings/0001666071-25-000135.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure | 0001666071-25-000135 |
| 2025-08-20 | 20:00 ET | [SCHEDULE 13D/A](/filings/0000921895-25-002345.md) | Ownership report, active investor, amended | 0000921895-25-002345 |
| 2025-08-06 | 20:32 ET | [10-Q](/filings/0001666071-25-000126.md) | Quarterly report, period 2025-06-30 | 0001666071-25-000126 |
| 2025-08-06 | 20:08 ET | [8-K](/filings/0001666071-25-000124.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001666071-25-000124 |
| 2025-07-08 | 12:01 ET | [8-K](/filings/0001666071-25-000119.md) | 1.01 Entry into a material agreement | 0001666071-25-000119 |
| 2025-06-25 | 20:08 ET | [8-K](/filings/0001666071-25-000105.md) | 5.02 Departure or appointment of officers or directors | 0001666071-25-000105 |
| 2025-05-20 | 20:04 ET | [8-K](/filings/0001666071-25-000075.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001666071-25-000075 |
| 2025-05-07 | 20:30 ET | [10-Q](/filings/0001666071-25-000069.md) | Quarterly report, period 2025-03-31 | 0001666071-25-000069 |
| 2025-05-07 | 20:07 ET | [8-K](/filings/0001666071-25-000067.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001666071-25-000067 |
| 2025-04-28 | 12:29 ET | [8-K](/filings/0001666071-25-000060.md) | 1.02 Termination of a material agreement; 8.01 Other events | 0001666071-25-000060 |
| 2025-04-03 | 20:04 ET | [DEF 14A](/filings/0001666071-25-000046.md) | Proxy statement, period 2025-04-03 | 0001666071-25-000046 |
| 2025-03-12 | 20:30 ET | [10-K](/filings/0001666071-25-000034.md) | Annual report, period 2024-12-31 | 0001666071-25-000034 |
| 2025-03-12 | 20:08 ET | [8-K](/filings/0001666071-25-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001666071-25-000033 |
| 2025-01-03 | 00:51 ET | [SCHEDULE 13D/A](/filings/0000921895-25-000040.md) | Ownership report, active investor, amended | 0000921895-25-000040 |
| 2024-11-06 | 21:31 ET | [10-Q](/filings/0001666071-24-000167.md) | Quarterly report, period 2024-09-30 | 0001666071-24-000167 |
| 2024-11-06 | 21:02 ET | [8-K](/filings/0001666071-24-000166.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001666071-24-000166 |
| 2024-11-04 | 21:04 ET | [8-K](/filings/0001666071-24-000158.md) | 5.02 Departure or appointment of officers or directors | 0001666071-24-000158 |
| 2024-10-03 | 20:03 ET | [8-K](/filings/0001666071-24-000152.md) | 1.01 Entry into a material agreement | 0001666071-24-000152 |
| 2024-08-21 | 20:05 ET | [8-K/A](/filings/0001666071-24-000140.md) | 5.02 Departure or appointment of officers or directors | 0001666071-24-000140 |
| 2024-08-07 | 20:30 ET | [10-Q](/filings/0001666071-24-000130.md) | Quarterly report, period 2024-06-30 | 0001666071-24-000130 |
| 2024-08-07 | 20:16 ET | [8-K](/filings/0001666071-24-000129.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001666071-24-000129 |
| 2024-07-02 | 23:05 ET | [SC 13D/A](/filings/0000921895-24-001530.md) | Ownership report, active investor, amended | 0000921895-24-001530 |
| 2024-05-23 | 20:09 ET | [8-K](/filings/0001666071-24-000097.md) | 5.07 Shareholder vote results | 0001666071-24-000097 |
| 2024-05-08 | 20:31 ET | [10-Q](/filings/0001666071-24-000094.md) | Quarterly report, period 2024-03-31 | 0001666071-24-000094 |
| 2024-05-08 | 20:07 ET | [8-K](/filings/0001666071-24-000092.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001666071-24-000092 |
| 2024-04-12 | 20:09 ET | [DEF 14A](/filings/0001666071-24-000077.md) | Proxy statement, period 2024-04-12 | 0001666071-24-000077 |
| 2024-04-09 | 20:03 ET | [8-K](/filings/0001666071-24-000063.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001666071-24-000063 |
| 2024-04-01 | 20:50 ET | [8-K](/filings/0001666071-24-000053.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001666071-24-000053 |
| 2024-03-29 | 21:05 ET | [SC 13D/A](/filings/0000921895-24-000749.md) | Ownership report, active investor, amended | 0000921895-24-000749 |
| 2024-03-18 | 23:46 ET | [SC 13D/A](/filings/0001193805-24-000389.md) | Ownership report, active investor, amended | 0001193805-24-000389 |
| 2024-03-18 | 20:06 ET | [8-K](/filings/0001666071-24-000042.md) | 7.01 Regulation FD disclosure | 0001666071-24-000042 |
| 2024-03-18 | 11:30 ET | [8-K](/filings/0001666071-24-000039.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001666071-24-000039 |
| 2024-03-14 | 20:31 ET | [10-K](/filings/0001666071-24-000037.md) | Annual report, period 2023-12-31 | 0001666071-24-000037 |

Page 1 of 4. [Older](/companies/cdlx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.